A phase-I, open label clinical trial to assess the safety & tolerability of qHPV vaccine manufactured by Serum Institute of India Pvt. Ltd. in adults

A phase-I, open label clinical trial to assess the safety & tolerability of qHPV vaccine manufactured by Serum Institute of India Pvt. Ltd. in adults

Background: This first in human study was designed as an open label clinical trial to assess safety and tolerability of Serum Institute of India Pvt. Ltd. (SIIPL) quadrivalent HPV (qHPV) vaccine. Methods: A total of 48 healthy male and female (24 each) adult volunteers were administered a 0.5 ml sin...

Full description

Bibliographic Details
Main Authors: Hitt Sharma, K. Anil, Sameer Parekh, Pramod Pujari, Sunil Shewale, Shivani Desai, R.L. Madhusudhan, Jaya Patel, Anand Eswaraiah, Harish Rao, Sunil Gairola, Umesh Shaligram
Format: Article
Language:English
Published: Elsevier 2023-08-01
Series:Vaccine: X
Subjects:
qHPV
Safety
Adult
Phase I
Vaccine
Online Access:http://www.sciencedirect.com/science/article/pii/S2590136223000542

Internet

http://www.sciencedirect.com/science/article/pii/S2590136223000542

Similar Items